Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting-Reference-Cited by-同舟云学术

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

Published:2010-04-01 Issue:7 Volume:116 Page:1767-1775
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ku Geoffrey Y.,Yuan Jianda,Page David B.,Schroeder Sebastian E. A.,Panageas Katherine S.,Carvajal Richard D.,Chapman Paul B.,Schwartz Gary K.,Allison James P.,Wolchok Jedd D.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24951/fullpdf

Reference28 articles.

1. American Cancer Society. Cancer Facts and Figures, 2008. Available at: http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf Accessed June 30, 2009.

2. High-dose recombinant interleukin-2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol.,1999

3. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials;Eigentler;Lancet Oncol.,2003

4. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma;Chapman;J Clin Oncol.,1999

5. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation;Krummel;J Exp Med.,1995

Cited by 397 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the impact of radiation-induced lymphopenia: Preclinical and clinical research perspectives;Clinical and Translational Radiation Oncology;2024-11

2. Clinical Translation of a Deep Learning Model of Radiation-Induced Lymphopenia for Esophageal Cancer;International Journal of Particle Therapy;2024-09

3. Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors;BJC Reports;2024-04-18

4. Mechanism of Action and Pharmacologic Features of Drugs Targeting PD ‐1/ PDL ‐1 and CTLA ‐4;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

5. Prognostic implications of neutrophil‐to‐lymphocyte ratio in patients with extensive‐stage small cell lung cancer receiving chemoimmunotherapy: A multicenter, real‐world study;Thoracic Cancer;2024-01-31